Richard Akele

Dr. Richard Akele is a Senior Lecturer in the School of Applied Sciences at the University of Brighton, affiliated with the Centre for Regenerative Medicine and Devices. His research focuses on cancer immunology, tumor microenvironment (TME) modeling via 3D bioprinting, and infectious diseases including vaccine development. He holds adjunct senior lecturer roles and has served as a Fitness to Practice Panel Member at the HCPC. Akele earned a PhD in biomarkers of cerebral malaria from the University of Benin and multiple academic qualifications from the University of Brighton.

His research integrates immunology and engineering, developing bioprinted models to study immune-tumor interactions and regenerative therapies. Key areas include neuro-oncology, vaccine efficacy analysis, and pandemic preparedness. Akele has published extensively on topics like mpox prevention, dengue fever treatments, and public health responses to emerging pathogens. His work bridges laboratory science with clinical applications, emphasizing global health equity and disease prevention strategies.

Dr. Akele's teaching philosophy emphasizes student-centered learning through active engagement and technology integration. He supervises graduate research in cancer biology, TME modulation, and infectious immunology. His contributions span over 45 peer-reviewed articles, with recent focus on pandemic-related studies and bioprinting innovations.